
Shenzhen YHLO Biotech Co Investor Relations Material
Latest events

Q4 2024
25 Apr, 2025

Q1 2025
25 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shenzhen YHLO Biotech Co
Access all reports
Shenzhen YHLO Biotech Co., Ltd., founded in 2008, is a Chinese company primarily focused on the research, development, manufacture, and sale of in-vitro diagnostic equipment and supporting reagents. The company's extensive product portfolio includes instruments and reagents based on chemiluminescence immunoassay, immunoblotting, enzyme-linked immunoassay, and immunofluorescence chromatography. These products are used in various medical fields, including autoimmunity, reproductive health, diabetes, and infectious diseases. The company is headquartered in Shenzhen, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
688575
Country
🇨🇳 China